Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
105151687	10515168	7	F	20140710	20160901	20141014	20160907	EXP		PHHY2014DE133159	NOVARTIS		43.00	YR		F	Y	67.00000	KG	20160907		MD	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
105151687	10515168	1	PS	GILENYA	FINGOLIMOD HYDROCHLORIDE	1	Oral	0.5 MG, QD	116.996002	MG	Y				22527	.5	MG	CAPSULE	QD
105151687	10515168	2	C	FAMPYRA	DALFAMPRIDINE	1	Oral	10 MG, BID							0	10	MG		BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
105151687	10515168	1	Multiple sclerosis
105151687	10515168	2	Muscle spasticity

Outcome of event

Event ID	CASEID	OUTC COD
105151687	10515168	HO
105151687	10515168	OT

Reactions reported

Event ID	CASEID	PT
105151687	10515168	Breast cancer stage II
105151687	10515168	Multiple sclerosis relapse
105151687	10515168	Pyrexia
105151687	10515168	Restless legs syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
105151687	10515168	1	20131212	201410	0
105151687	10515168	2	20130411		0